Left Main Coronary Artery Stenting: Risks, Benefits & Considerations

Percutaneous coronary intervention (PCI) of the left main coronary artery (LMCA) is a high-risk, complex procedure reserved for select patients.

Indications

  • Severe LMCA stenosis (>50%) with unstable angina or NSTEMI
  • Unsuitable for coronary artery bypass grafting (CABG) due to comorbidities, frailty, or patient preference
  • Heart Team consensus (interventional cardiologist + cardiac surgeon)

Key Risks

  • Periprocedural MI, stroke, death (higher than non-LMCA PCI)
  • Stent thrombosis
  • Restenosis (lower with drug-eluting stents)
  • Distal embolization

Stent Selection

Drug-eluting stents (DES) are strongly preferred over bare-metal stents (BMS) due to significantly lower restenosis and target lesion revascularization rates. Newer-generation DES (everolimus, zotarolimus) have improved safety profiles.

Procedural Considerations

  • Intravascular imaging (IVUS/OCT) mandatory for optimal sizing and apposition
  • Provisional T-stenting or culotte technique for bifurcation lesions
  • Prolonged dual antiplatelet therapy (DAPT) – typically ≥12 months

Shared decision-making with the Heart Team and patient is essential, weighing LMCA-PCI against CABG and medical therapy.

Cardiovascular Disease - Related Articles